Literature DB >> 27709448

A pooled analysis of the association of isolated low levels of high-density lipoprotein cholesterol with cardiovascular mortality in Japan.

Takumi Hirata1, Daisuke Sugiyama2, Shin-Ya Nagasawa3, Yoshitaka Murakami4, Shigeyuki Saitoh5, Akira Okayama6, Hiroyasu Iso7, Fujiko Irie8, Toshimi Sairenchi9, Yoshihiro Miyamoto10, Michiko Yamada11, Shizukiyo Ishikawa12, Katsuyuki Miura13, Hirotsugu Ueshima14, Tomonori Okamura2.   

Abstract

Low levels of serum high-density lipoprotein cholesterol (HDL-C) have been shown to be associated with increased risk of coronary heart disease (CHD). However, because this is usually observed in the context of other lipid abnormalities, it is not known whether isolated low serum HDL-C levels are an independent risk factor for CHD. We performed a large pooled analysis in Japan using data from nine cohorts with 41,206 participants aged 40-89 years who were free of cardiovascular disease at baseline. We divided participants into three groups: isolated low HDL-C, non-isolated low HDL-C, and normal HDL-C. Cohort-stratified Cox proportional hazards models were used to estimate multivariate-adjusted hazard ratios (HRs) for death due to CHD, ischemic stroke, and intracranial cerebral hemorrhage; during a 12.9-year follow-up, we observed 355, 286, and 138 deaths, respectively, in these groups. Non-isolated low HDL-C was significantly associated with increased risk of CHD compared with normal HDL-C (HR 1.37, 95 % confidence interval (CI) 1.04-1.80); however, isolated low HDL-C was not. Although isolated low HDL-C was significantly associated with decreased risk of CHD (HR 0.51, 95 % CI 0.29-0.89) in women, it was significantly associated with increased risk of intracranial cerebral hemorrhage in all participants (HR 1.62, 95 % CI 1.04-2.53) and in men (HR 2.00, 95 % CI 1.04-3.83). In conclusion, isolated low HDL-C levels are not associated with increased risk of CHD in Japan. CHD risk may, therefore, be more strongly affected by serum total cholesterol levels in this population.

Entities:  

Keywords:  Cardiovascular diseases; Epidemiology; High-density lipoprotein cholesterol; Mortality

Mesh:

Substances:

Year:  2016        PMID: 27709448     DOI: 10.1007/s10654-016-0203-1

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  35 in total

1.  Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

Authors:  M A Austin; M C King; K M Vranizan; R M Krauss
Journal:  Circulation       Date:  1990-08       Impact factor: 29.690

Review 2.  High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: a systematic review.

Authors:  Pierre Amarenco; Julien Labreuche; Pierre-Jean Touboul
Journal:  Atherosclerosis       Date:  2007-10-17       Impact factor: 5.162

3.  Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.

Authors:  William E Boden; Jeffrey L Probstfield; Todd Anderson; Bernard R Chaitman; Patrice Desvignes-Nickens; Kent Koprowicz; Ruth McBride; Koon Teo; William Weintraub
Journal:  N Engl J Med       Date:  2011-11-15       Impact factor: 91.245

4.  Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region.

Authors:  A Patel; F Barzi; K Jamrozik; T H Lam; H Ueshima; G Whitlock; M Woodward
Journal:  Circulation       Date:  2004-10-18       Impact factor: 29.690

5.  Cholesterol, coronary heart disease, and stroke in the Asia Pacific region.

Authors:  X Zhang; A Patel; H Horibe; Z Wu; F Barzi; A Rodgers; S MacMahon; M Woodward
Journal:  Int J Epidemiol       Date:  2003-08       Impact factor: 7.196

Review 6.  Treating high density lipoprotein cholesterol (HDL-C): quantity versus quality.

Authors:  Angela Pirillo; Giuseppe Danilo Norata; Alberico Luigi Catapano
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 7.  Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.

Authors:  Mark J Cziraky; Karol E Watson; Robert L Talbert
Journal:  J Manag Care Pharm       Date:  2008-10

8.  Relation between serum total cholesterol level and cardiovascular disease stratified by sex and age group: a pooled analysis of 65 594 individuals from 10 cohort studies in Japan.

Authors:  Sin-ya Nagasawa; Tomonori Okamura; Hiroyasu Iso; Akiko Tamakoshi; Michiko Yamada; Makoto Watanabe; Yoshitaka Murakami; Katsuyuki Miura; Hirotsugu Ueshima
Journal:  J Am Heart Assoc       Date:  2012-10-25       Impact factor: 5.501

Review 9.  The independent relationship between triglycerides and coronary heart disease.

Authors:  Alan Morrison; John E Hokanson
Journal:  Vasc Health Risk Manag       Date:  2009-04-08

Review 10.  Current guidelines for high-density lipoprotein cholesterol in therapy and future directions.

Authors:  Bishnu H Subedi; Parag H Joshi; Steven R Jones; Seth S Martin; Michael J Blaha; Erin D Michos
Journal:  Vasc Health Risk Manag       Date:  2014-04-08
View more
  7 in total

1.  Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Authors:  Makoto Kinoshita; Koutaro Yokote; Hidenori Arai; Mami Iida; Yasushi Ishigaki; Shun Ishibashi; Seiji Umemoto; Genshi Egusa; Hirotoshi Ohmura; Tomonori Okamura; Shinji Kihara; Shinji Koba; Isao Saito; Tetsuo Shoji; Hiroyuki Daida; Kazuhisa Tsukamoto; Juno Deguchi; Seitaro Dohi; Kazushige Dobashi; Hirotoshi Hamaguchi; Masumi Hara; Takafumi Hiro; Sadatoshi Biro; Yoshio Fujioka; Chizuko Maruyama; Yoshihiro Miyamoto; Yoshitaka Murakami; Masayuki Yokode; Hiroshi Yoshida; Hiromi Rakugi; Akihiko Wakatsuki; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2018-08-22       Impact factor: 4.928

2.  Impact of hypertension stratified by diabetes on the lifetime risk of cardiovascular disease mortality in Japan: a pooled analysis of data from the Evidence for Cardiovascular Prevention from Observational Cohorts in Japan study.

Authors:  Yukiko Imai; Takumi Hirata; Shigeyuki Saitoh; Toshiharu Ninomiya; Yoshihiro Miyamoto; Hirofumi Ohnishi; Yoshitaka Murakami; Hiroyasu Iso; Sachiko Tanaka; Katsuyuki Miura; Akiko Tamakoshi; Michiko Yamada; Masahiko Kiyama; Hirotsugu Ueshima; Shizukiyo Ishikawa; Tomonori Okamura
Journal:  Hypertens Res       Date:  2020-07-03       Impact factor: 3.872

Review 3.  Atherosclerotic Cardiovascular Risk in Japan.

Authors:  Shuko Nojiri; Hiroyuki Daida
Journal:  Jpn Clin Med       Date:  2017-06-19

4.  Isolated low levels of high-density lipoprotein cholesterol and stroke incidence: JMS Cohort Study.

Authors:  Jun Watanabe; Eiichi Kakehi; Kazuhiko Kotani; Kazunori Kayaba; Yosikazu Nakamura; Shizukiyo Ishikawa
Journal:  J Clin Lab Anal       Date:  2019-11-19       Impact factor: 2.352

5.  Association of High-Density Lipoprotein Cholesterol Phenotypes with the Risk of Cardiovascular Diseases and Mortality: A Cohort Study in Korea.

Authors:  Ga Eun Nam; Youn Huh; Jin-Hyung Jung; Kyungdo Han; Seon Mee Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2022-04-25

6.  Total cholesterol and mortality from ischemic heart disease and overall cardiovascular disease in Korean adults.

Authors:  Daeho Kwon; Jee-Jeon Yi; Heechoul Ohrr; Sang-Wook Yi
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

7.  High-Density Lipoprotein Cholesterol and Cardiovascular Events in Patients with Stable Coronary Artery Disease Treated with Statins: An Observation from the REAL-CAD Study.

Authors:  Kazunori Omote; Isao Yokota; Toshiyuki Nagai; Ichiro Sakuma; Yoshihisa Nakagawa; Kiwamu Kamiya; Hiroshi Iwata; Katsumi Miyauchi; Yukio Ozaki; Kiyoshi Hibi; Takafumi Hiro; Yoshihiro Fukumoto; Hiroyoshi Mori; Seiji Hokimoto; Yasuo Ohashi; Hiroshi Ohtsu; Hisao Ogawa; Hiroyuki Daida; Satoshi Iimuro; Hiroaki Shimokawa; Yasushi Saito; Takeshi Kimura; Masunori Matsuzaki; Ryozo Nagai; Toshihisa Anzai
Journal:  J Atheroscler Thromb       Date:  2021-01-09       Impact factor: 4.928

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.